Corvus Pharmaceuticals Inc. (CRVS) Dropped -5.8% or -0.57 To Price $9.26 On Tuesday


Corvus Pharmaceuticals Inc. (CRVS) dropped -5.8% or -0.57 to $9.26. It is near 29868 shares traded, which is 43.84% compare to the average total volume 68128. The market cap of CRVS is $270.33 million. The year to date change is -12.0%. The 52 week price range is from $7.42 to $17.64. Price of CRVS have changed 1.34% during last week. It have changed -9.23% over last month, 20.61% over last 3 months, -18.96% over last 6 months and -8.47% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CRVS is 10.26. It is 10.80% above current price. The 200-day Moving Averages for CRVS is 11.78. It is 27.21% above current price. The 52-week High is 17.64. It is 90.50% from the current price. The 52-week Low is 7.42. It is -19.87% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CRVS is 13.39 on 2018-04-30. Short % to float is 3.71%. There are some statistics of CRVS. It is has market cap $270.33 million. The share outstanding is 29.19 million. The average volume is 68128. The percent of top 15 Institution holding is 68.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CRVS is -39.36%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CRVS is -36.47%.


Tags:

Share this post